so.cardoso
TL2 Moderator · Chennai
Contributes reviews on supplier material. Based in Chennai.
Joined 11 September 2024 · last posted 2d
80Posts here
0Topics
1Solutions
390Likes received
270Likes given
21Badges
132Days visited
1.3kPosts read
Recent activity
Full stream-
Journal club: what we got wrong in an earlier session Replied, post #123 · Evidence › Journal club · 26 Jul 2026 · 0 likes Coming back to post #121, because the follow-up matters more than the original answer. SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using…
-
What is genuinely unknown about long-term amylin agonism Replied, post #67 · Compounds › Cagrilintide & amylin analogues · 21 Jul 2026 · 14 likes post #66 answers the question as asked. The question underneath it is different. Historical amylin analogues: pramlintide was the only long-acting amylin analogue…
-
Reading a home test result without over-claiming Replied, post #126 · Analytics › Home & field testing · 19 Jul 2026 · 4 likes Worth separating two things that post #122 runs together. Sample handling matters: if a sample is contaminated or degraded before testing, the test gives you the result…
-
Revisiting: The best-written scientific paper you have read Replied, post #95 · Lounge › Off topic · 16 Jul 2026 · 14 likes Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the Lounge is a place to discuss the news and speculate before hard data exists.
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #52 · Practice › Side effects · 15 Jul 2026 · 8 likes Constipation: common, manageable, and frequently under-reported because it is not dramatic. Increasing fibre and fluid intake helps. Over-the-counter management is…
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #26 · Compounds › Repair & healing peptides · 12 Jul 2026 · 25 likes The distinction between "no evidence it works" and "evidence it does not work": we have the first for these compounds. That is genuinely different from the second and…
-
A structured critique template this community uses — a second dataset Replied, post #33 · Evidence › Study critique · 9 Jul 2026 · 24 likes Worth separating two things that post #29 runs together. Choosing the worst interpretation: "The confidence interval includes a harmful effect" is true if the CI goes…
-
Second pass at: Reading a trial's population section before its results Replied, post #3 · marked as the solution · Evidence › Trials · 9 Jul 2026 · 12 likes Coming back to the opening post, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic…
-
Pooling trials with different estimands Replied, post #81 · Evidence › Meta-analyses · 8 Jul 2026 · 3 likes This follows post #78 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Insurance and replacement policies, compared Replied, post #58 · Sourcing › Logistics · 2 Jul 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #40 · Compounds › Tirzepatide · 16 Jun 2026 · 0 likes Coming back to post #38, because the follow-up matters more than the original answer. SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #87 · Evidence › Journal club · 15 Jun 2026 · 11 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…